Literature DB >> 3721771

Cycloserine as a urinary tract antiseptic.

P Kaltenis.   

Abstract

A short historical review and pharmacological data indicating the suitability of cycloserine for long-term low-dose prophylaxis of urinary tract infection are presented.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3721771     DOI： 10.1007/bf02082597

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  32 in total

1.  Antibacterial activity and blood and urine concentrations of cycloserine, a new antibiotic, following oral administration.

Authors:  H WELCH; L E PUTNAM; W A RANDALL
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1955-02

2.  Reversal of cycloserine inhibition by D-alanine.

Authors:  G D SHOCKMAN
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

3.  Some considerations in the administration of novobiocin and cycloserine.

Authors:  R D HERROLD
Journal:  J Urol       Date:  1957-05       Impact factor: 7.450

4.  The treatment of stubborn urinary infections with a new antibiotic: cycloserine.

Authors:  R D HERROLD; A V BOAND; M KAMP
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1955-12

5.  Selection of antibiotics in acute pyelonephritis based on renal interstitial (lymph) concentrations.

Authors:  A T Cockett; A P Roberts; R S Moore; W E Goodwin
Journal:  Br J Urol       Date:  1968-10

6.  The rythm of absorption and elimination of cycloserine as studied with the chromatographic technique.

Authors:  P Georgescu; E Săvuleanu; I Daniello
Journal:  Scand J Respir Dis Suppl       Date:  1970

7.  [Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].

Authors:  N A Shmelev; L N Shabalova; V P Kolosovskaia
Journal:  Antibiotiki       Date:  1975-02

Review 8.  Prevention of urinary tract infections.

Authors:  W E Stamm
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

9.  In vitro activity of fludalanine combined with pentizidone compared with those of other agents.

Authors:  R Wise; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

10.  Adverse reactions to nitrofurantoin. Analysis of 921 reports.

Authors:  L Holmberg; G Boman; L E Böttiger; B Eriksson; R Spross; A Wessling
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965
View more
  1 in total

1.  Cycloserine as an alternative urinary tract infection therapy: susceptibilities of 500 urinary pathogens to standard and alternative therapy antimicrobials.

Authors:  R Kugathasan; M Wootton; R Howe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-29       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.